연구용

Sunitinib (SU-11248) 다중 표적 수용체 티로신 키나아제 억제제

제품 번호S7781

Sunitinib은 VEGFR2 (Flk-1) 및 PDGFRβ를 IC50 80 nM 및 2 nM로 표적화하는 다중 표적 RTK 억제제이며, c-Kit도 억제합니다. Sunitinib은 또한 IRE1α의 자가인산화 활성을 용량 의존적으로 억제합니다. Sunitinib은 autophagy 및 apoptosis를 유도합니다.

Sunitinib (SU-11248) PDGFR 억제제 Chemical Structure

화학 구조

분자량: 398.47

바로가기

품질 관리

배치: 순도: 99.84%

99.84

관련 타겟	EGFR VEGFR FGFR c-Met Src MEK CSF-1R FLT3 HER2 c-Kit
기타 PDGFR 억제제	CP-673451 Orantinib (SU6668) Tyrphostin AG 1296 Trapidil PP121 AZD2932 Sennoside B Tyrphostin AG1433 Seralutinib (GB002) N-(p-Coumaroyl) Serotonin

세포 배양, 처리 및 작업 농도

세포주	분석 유형	농도	배양 시간	활성 설명	PMID
HUVEC cell	Function assay		24 h	Inhibition of VEGF-A induced HUVEC cell sprouting after 24 hrs by angiogenesis assay, IC50=0.12 μM	21741249
HEK293	Function assay			Binding affinity to FLT3 catalytic domain expressed in HEK293 cells by competitive binding assay, Kd = 0.00047 μM.	19754199
MV4-11	Antiproliferative assay		72 hrs	Antiproliferative activity against FLT3-ITD dependent human MV4-11 cells assessed as reduction in cell viability after 72 hrs by celltiter-glo/CCK8 assay, GI50 = 0.001 μM.	27077705
HL60	Antiproliferative assay		72 hrs	Antiproliferative activity against human HL60 cells assessed as reduction in cell viability after 72 hrs by celltiter-glo/CCK8 assay, GI50 = 0.001 μM.	27077705
BAF3	Function assay		72 hrs	Inhibition of Tel-fused cKIT T670I mutant (unknown origin) transfected in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by celltiter-glo/CCK8 assay, GI50 = 0.002 μM.	27077705
MV4-11	Cytotoxicity assay		72 hrs	Cytotoxicity against FLT3-dependent human MV4-11 cells after 72 hrs by MTT assay, IC50 = 0.003 μM.	22452518
MV411	Antiproliferative assay		48 hrs	Antiproliferative activity against human MV411 cells after 48 hrs by MTT assay, IC50 = 0.003 μM.	24904961
BA/F3	Function assay		72 hrs	Inhibition of Kit exon 11 deletion (557 to 558 residues) mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50 = 0.004 μM.	30204441
MV4-11	Antiproliferative assay		72 hrs	Antiproliferative activity against human MV4-11 cells after 72 hrs by cell titer-blue cell viability assay, IC50 = 0.0043 μM.	19754199
MV4-11	Cytotoxicity assay		72 hrs	Cytotoxicity against human MV4-11 cells after 72 hrs by cell titer-blue assay, IC50 = 0.0043 μM.	19654408
Sf21	Function assay		60 mins	Inhibition of recombinant human N-terminal His6-tagged KDR (790 to end residues) expressed in baculovirus infected Sf21 insect cells after 60 mins by ELISA, IC50 = 0.0047 μM.	30241010
BA/F3	Function assay		72 hrs	Inhibition of Kit exon 11 deletion (557 to 558 residues) and D816H mutant and T670I mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50 = 0.005 μM.	30204441
MOLM14	Antiproliferative assay		72 hrs	Antiproliferative activity against FLT3-ITD dependent human MOLM14 cells assessed as reduction in cell viability after 72 hrs by celltiter-glo/CCK8 assay, GI50 = 0.005 μM.	27077705
BA/F3	Function assay		72 hrs	Inhibition of Kit exon 11 deletion (557 to 558 residues) and V654A mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50 = 0.006 μM.	30204441
BAF3	Function assay		72 hrs	Inhibition of Tel-fused cKIT V559D/V654A double mutant (unknown origin) transfected in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by celltiter-glo/CCK8 assay, GI50 = 0.006 μM.	27077705
MDA-MB-468	Cytotoxicity assay			Cytotoxicity against human triple negative MDA-MB-468 cells, IC50 = 0.0061 μM.	24890652
3T3	Function assay			Inhibition of PDGF-induced BrdU incorporation in 3T3 cells without bovine serum albumin, IC50 = 0.007 μM.	12646019
3T3	Function assay			Inhibition of PDGF-induced BrdU incorporation in 3T3 cells with 0.1% bovine serum albumin, IC50 = 0.007 μM.	12646019
3T3	Function assay			Inhibition of PDGF-induced BrdU incorporation in 3T3 cells with 0.5% bovine serum albumin, IC50 = 0.007 μM.	12646019
BA/F3	Function assay		72 hrs	Inhibition of Kit exon 9 AY502 to 503 insertion mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50 = 0.007 μM.	30204441
BA/F3	Function assay		72 hrs	Inhibition of Kit V560D/V654A mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50 = 0.007 μM.	30204441
3T3	Function assay			Inhibition of PDGF-induced BrdU incorporation in 3T3 cells with 1% bovine serum albumin, IC50 = 0.008 μM.	12646019
3T3	Function assay			Inhibition of PDGF-induced BrdU incorporation in 3T3 cells, IC50 = 0.008 μM.	12646019
MV4-11	Antiproliferative assay		72 hrs	Antiproliferative activity against human MV4-11 cells after 72 hrs by MTT assay, IC50 = 0.009 μM.	20570526
MV4-11	Cytotoxicity assay			Cytotoxicity against human MV4-11 cells by MTT assay, IC50 = 0.009 μM.	20833039
BAF3	Function assay		72 hrs	Inhibition of Tel-fused cKIT V559D mutant (unknown origin) transfected in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by celltiter-glo/CCK8 assay, GI50 = 0.009 μM.	27077705
endothelial precursor cells	Function assay			Inhibition of endothelial cord area formation in endothelial precursor cells by CD31 cord area detection based phenotypic drug discovery based assay, IC50 = 0.0096 μM.	22409666
MDA-MB-435	Cytotoxicity assay			Cytotoxicity against human MDA-MB-435 cells, IC50 = 0.0097 μM.	24890652
RS4-11	Function assay		2 hrs	Inhibition of FLT3 autophosphorylation in human RS4-11 cells after 2 hrs by electrochemiluminescence assay, IC50 = 0.0099 μM.	19654408
MV4-11	Antiproliferative assay		72 hrs	Antiproliferative activity against human MV4-11 cells after 72 hrs by Celltiter-Glo luminescent cell viability assay, IC50 = 0.01 μM.	29935772
BA/F3	Function assay		72 hrs	Inhibition of Kit exon 9 AY502 to 503 insertion and V654 mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50 = 0.012 μM.	30204441
Kasumi-1	Antiproliferative assay		72 hrs	Antiproliferative activity against human Kasumi-1 cells after 72 hrs by MTT assay, IC50 = 0.016 μM.	20570526
RS4-11	Function assay			Inhibition of FLT3 autophosphorylation in human RS4-11 cells by Western blot analysis, IC50 = 0.016 μM.	20833039
4T1	Cytotoxicity assay			Cytotoxicity against mouse triple negative 4T1 cells, IC50 = 0.016 μM.	24890652
MOLM13	Cytotoxicity assay		48 hrs	Cytotoxicity against human MOLM13 cells assessed as cell viability after 48 hrs by MTT assay, IC50 = 0.0177 μM.	25089810
NIH3T3	Function assay		1 hr	Inhibitory concentration against human KDR kinase expressed in NIH3T3 cells with 4 uM Biotin-Ahx-AEEEYFFLFA-amide at ambient temperature for 1 hr, IC50 = 0.018 μM.	16162008
U251	Function assay			Inhibition of VEGFR2 in human U251 cells by phosphotyrosine ELISA, IC50 = 0.0189 μM.	24900865
U251	Function assay			Inhibition of VEGFR2 in human U251 cells by phosphotyrosine ELISA assay, IC50 = 0.0189 μM.	24890652
U251	Function assay		60 mins	Inhibition of VEGF-induced VEGFR2 activation in human U251 cells pretreated for 60 mins followed by VEGF addition and measured after 10 mins by ELISA, IC50 = 0.0189 μM.	30098869
U251	Function assay		60 mins	Inhibition of VEGFR-2 in human U251 cells assessed as reduction in VEGF induced phosphorylation preincubated for 60 mins followed by VEGF addition measured after 10 mins by ELISA method, IC50 = 0.0189 μM.	27894589
U251	Function assay		60 min	Inhibition of VEGFR2 in human U251 cells compound pretreated for 60 min before VEGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method, IC50 = 0.0189 μM.	25882519
BAF3	Function assay		72 hrs	Inhibition of Tel-fused cKIT V654A mutant (unknown origin) transfected in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by celltiter-glo/CCK8 assay, GI50 = 0.02 μM.	27077705
MDA-MB-231	Cytotoxicity assay			Cytotoxicity against human triple negative MDA-MB-231 cells, IC50 = 0.0223 μM.	24890652
BAF3	Function assay		72 hrs	Inhibition of Tel-fused cKIT L567P mutant (unknown origin) transfected in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by celltiter-glo/CCK8 assay, GI50 = 0.023 μM.	27077705
BA/F3	Function assay		72 hrs	Inhibition of Kit exon 11 deletion (560 to 578 residues) mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50 = 0.024 μM.	30204441
MV4-11	Cytotoxicity assay		48 hrs	Cytotoxicity against human MV4-11 cells assessed as cell viability after 48 hrs by MTT assay, IC50 = 0.0243 μM.	25089810
BA/F3	Function assay		72 hrs	Inhibition of Kit V560D mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50 = 0.027 μM.	30204441
MCF7	Cytotoxicity assay			Cytotoxicity against human ER-positive MCF7 cells, IC50 = 0.0271 μM.	24890652
MCF7	Cytotoxicity assay			Cytotoxicity against human taxoid-resistant MCF7 cells, IC50 = 0.0293 μM.	24890652
primary leukemia cells	Cytotoxicity assay		72 hrs	Cytotoxicity against human primary leukemia cells isolated from acute myeloid leukemia patient expressing FLT3-ITD mutation assessed as cell viability after 72 hrs by luciferase assay, IC50 = 0.03 μM.	22221201
primary leukemia cells	Cytotoxicity assay		72 hrs	Cytotoxicity against human primary leukemia cells isolated from acute myeloid leukemia patient expressing wild type FLT3 assessed as cell viability after 72 hrs by luciferase assay, IC50 = 0.03 μM.	22221201
BA/F3	Function assay		72 hrs	Inhibition of TEL-fused PDGFRalpha (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50 = 0.03 μM.	30204441
BA/F3	Function assay		72 hrs	Inhibition of KDR (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50 = 0.033 μM.	30204441
RS4-11	Function assay		2 hrs	Inhibition of FLT3 ITD mutant autophosphorylation in human RS4-11 cells after 2 hrs by electrochemiluminescence assay, IC50 = 0.034 μM.	19654408
HL60	Cytotoxicity assay		48 hrs	Cytotoxicity against human HL60 cells assessed as cell viability after 48 hrs by MTT assay, IC50 = 0.0368 μM.	25089810
MV4-11	Antiproliferative assay		72 hrs	Antiproliferative activity against human MV4-11 cells harboring FLT3 ITD mutant after 72 hrs by MTS assay, IC50 = 0.0385 μM.	28038328
TT	Antiproliferative assay		72 hrs	Antiproliferative activity against human TT cells pretreated for 72 hrs followed by compound-washout measured after 72 hrs by MTT assay, IC50 = 0.04 μM.	24904961
GISTT1	Cytotoxicity assay		72 hrs	Cytotoxicity against human GISTT1 cells assessed as cell growth inhibition after 72 hrs by CellTiterGlo assay, GI50 = 0.04 μM.	28991465
GISTT1	Antiproliferative assay		72 hrs	Antiproliferative activity against cKIT dependent human GISTT1 cells assessed as reduction in cell viability after 72 hrs by celltiter-glo/CCK8 assay, GI50 = 0.041 μM.	27077705
THP1	Cytotoxicity assay		48 hrs	Cytotoxicity against human THP1 cells assessed as cell viability after 48 hrs by MTT assay, IC50 = 0.0457 μM.	25089810
3T3	Function assay			Inhibition of Vascular endothelial growth factor receptor in 3T3 cells, IC50 = 0.05 μM.	12646019
BAF3	Function assay		72 hrs	Inhibition of Tel-fused cKIT T670I/V559D double mutant (unknown origin) transfected in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by celltiter-glo/CCK8 assay, GI50 = 0.053 μM.	27077705
BAF3	Function assay		72 hrs	Inhibition of Tel-fused cKIT (unknown origin) transfected in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by celltiter-glo/CCK8 assay, GI50 = 0.078 μM.	27077705
3T3	Function assay			Inhibition of PDGF-induced BrdU incorporation in 3T3 cells with 5% bovine serum albumin, IC50 = 0.083 μM.	12646019
SH-SY5Y	Function assay			Inhibition of PDGFRbeta in human SH-SY5Y cells by phosphotyrosine ELISA assay, IC50 = 0.0831 μM.	24890652
SH-SY5Y	Function assay		60 mins	Inhibition of PDGF-BB-induced PDGFRbeta activation in human SH-SY5Y cells pretreated for 60 mins followed by PDGF-BB addition and measured after 10 mins by ELISA, IC50 = 0.0831 μM.	30098869
SF539	Function assay		60 mins	Inhibition of PDGFR-beta in human SF539 cells assessed as reduction in PDGF-BB induced phosphorylation preincubated for 60 mins followed by PDGF-BB addition measured after 10 mins by ELISA method, IC50 = 0.0831 μM.	27894589
U251	Function assay		60 min	Inhibition of PDGFR-beta in human U251 cells compound pretreated for 60 min before PDGF-BB stimulation for 10 mins by phosphotyrosine ELISA cytoblot method, IC50 = 0.0831 μM.	25882519
GISTT1	Cytotoxicity assay		72 hrs	Cytotoxicity against human GISTT1 cells harboring KIT T670I mutant assessed as cell growth inhibition after 72 hrs by CellTiterGlo assay, GI50 = 0.09 μM.	28991465
GIST430	Cytotoxicity assay		72 hrs	Cytotoxicity against human GIST430 cells harboring KIT V654A mutant assessed as cell growth inhibition after 72 hrs by CellTiterGlo assay, GI50 = 0.098 μM.	28991465
HAEC	Antiproliferative assay		72 hrs	Antiproliferative activity against human HAEC cells expressing VEGFR after 72 hrs by MTT assay, IC50 = 0.1 μM.	22444679
GIST882	Antiproliferative assay		72 hrs	Antiproliferative activity against cKIT dependent human GIST882 cells assessed as reduction in cell viability after 72 hrs by celltiter-glo/CCK8 assay, GI50 = 0.11 μM.	27077705
BA/F3	Function assay		72 hrs	Inhibition of TEL-fused PDGFRbeta (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50 = 0.114 μM.	30204441
FDC-P1	Function assay		48 hrs	Inhibition of human FMS expressed in growth factor dependent mouse FDC-P1 cells assessed as inhibition of FMS-mediated cell proliferation in presence human CSF1 after 48 hrs by resazurin dye reduction assay, IC50 = 0.155 μM.	20156689
A431	Function assay			Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay, IC50 = 0.1721 μM.	24890652
A431	Function assay		60 mins	Inhibition of EGF-induced EGFR activation in human A431 cells pretreated for 60 mins followed by EGF addition and measured after 10 mins by ELISA, IC50 = 0.1721 μM.	30098869
A431	Function assay		60 mins	Inhibition of EGFR in human A431 cells compound pretreated for 60 min before EGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method, IC50 = 0.1721 μM.	25882519
Sf9	Function assay			Inhibition of GST-tagged VEGFR expressed in Sf9 cells, IC50 = 0.185 μM.	19854051
BA/F3	Function assay		72 hrs	Inhibition of Kit exon 11 deletion (557 to 558 residues) and D820A mutant and D820A mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50 = 0.214 μM.	30204441
BaPTC2	Growth inhibition assay		72 hrs	Growth inhibition of mouse BaPTC2 cells assessed as incorporation of [3H]thymidine incorporation after 72 hrs by liquid scintillation counting, IC50 = 0.22 μM.	20117004
BA/F3	Function assay		72 hrs	Inhibition of Kit exon 11 deletion (557 to 558 residues) and N822K mutant and Y823D mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50 = 0.271 μM.	30204441
HT-29	Cytotoxicity assay		72 hrs	Cytotoxicity against VEGFR expressing human HT-29 cells after 72 hrs by MTT assay, IC50 = 0.33 μM.	23131541
HT-29	Antiproliferative assay		72 hrs	Antiproliferative activity against human HT-29 cells expressing VEGFR after 72 hrs by MTT assay, IC50 = 0.33 μM.	22444679
BA/F3	Function assay		72 hrs	Inhibition of Kit exon 11 deletion (557 to 558 residues) and D816H mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50 = 0.398 μM.	30204441
BA/F3	Function assay		72 hrs	Inhibition of Kit exon 11 deletion (557 to 558 residues) and A829P mutant and Y823D mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50 = 0.43 μM.	30204441
THP1	Antiproliferative assay		72 hrs	Antiproliferative activity against human THP1 cells after 72 hrs by MTT assay, IC50 = 0.5 μM.	20570526
CHO	Function assay			Inhibition of human ERG expressed in CHO cells by Qpatch assay, IC50 = 0.5 μM.	28038328
BAF3	Function assay		72 hrs	Inhibition of Tel-fused cKIT N822K mutant (unknown origin) transfected in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by celltiter-glo/CCK8 assay, GI50 = 0.51 μM.	27077705
BA/F3	Function assay		72 hrs	Inhibition of Kit exon 9 AY502 to 503 insertion and D816 mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50 = 0.584 μM.	30204441
CAKI-1	Antiproliferative assay		48 hrs	Antiproliferative activity against human CAKI-1 cells after 48 hrs by SRB assay, GI50 = 0.63 μM.	22560627
BA/F3	Function assay		72 hrs	Inhibition of PDGFRalpha V561D/D842V mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50 = 0.631 μM.	30204441
BA/F3	Function assay		72 hrs	Inhibition of Kit D816V mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50 = 0.638 μM.	30204441
BA/F3	Function assay		72 hrs	Inhibition of Kit V560D/D816H mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50 = 0.696 μM.	30204441
BA/F3	Function assay		72 hrs	Inhibition of Kit exon 11 deletion (557 to 558 residues) and Y823D mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay, GI50 = 0.782 μM.	30204441
NCI-H3122	Antiproliferative assay		72 hrs	Antiproliferative activity against human NCI-H3122 cells after 72 hrs by MTT assay, IC50 = 0.83 μM.	24904961
Rec1	Antiproliferative assay		72 hrs	Antiproliferative activity against human Rec1 cells assessed as reduction in cell viability after 72 hrs by celltiter-glo/CCK8 assay, GI50 = 0.87 μM.	27077705
RS4:11	Antiproliferative assay		72 hrs	Antiproliferative activity against human RS4:11 cells after 72 hrs by MTT assay, IC50 = 1 μM.	20570526
K562	Antiproliferative assay		72 hrs	Antiproliferative activity against BCR-ABL dependent human K562 cells assessed as reduction in cell viability after 72 hrs by celltiter-glo/CCK8 assay, GI50 = 1 μM.	27077705
NCI-H526	Antiproliferative assay		72 hrs	Antiproliferative activity against human NCI-H526 cells after 72 hrs by MTT assay, IC50 = 1.01 μM.	24904961
primary leukemia cells	Cytotoxicity assay		72 hrs	Cytotoxicity against human primary leukemia cells isolated from acute myeloid leukemia patient expressing FLT3-D835Y mutation assessed as cell viability after 72 hrs by luciferase assay, IC50 = 1.1 μM.	22221201
KU812	Antiproliferative assay		72 hrs	Antiproliferative activity against BCR-ABL dependent human KU812 cells assessed as reduction in cell viability after 72 hrs by celltiter-glo/CCK8 assay, GI50 = 1.1 μM.	27077705
BA/F3	Growth inhibition assay		72 hrs	Growth inhibition of mouse BA/F3 cells assessed as incorporation of [3H]thymidine incorporation after 72 hrs by liquid scintillation counting, IC50 = 1.2 μM.	20117004
MEG01	Antiproliferative assay		72 hrs	Antiproliferative activity against human BCR-ABL dependent MEG01 cells assessed as reduction in cell viability after 72 hrs by celltiter-glo/CCK8 assay, GI50 = 1.2 μM.	27077705
Sf9	Function assay			Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells, IC50 = 1.3 μM.	20117004
HT-29	Cytotoxicity assay		72 hrs	Cytotoxicity against human HT-29 cells assessed as cell growth inhibition after 72 hrs by MTT assay, IC50 = 1.3 μM.	21621880
SW620	Antiproliferative assay		48 hrs	Antiproliferative activity against human SW620 cells after 48 hrs by SRB assay, GI50 = 1.3 μM.	22560627
IM9	Antitumor assay			Antitumor activity against human IM9 cells, IC50 = 1.35 μM.	21450463
BAF3	Function assay		72 hrs	Inhibition of Tel-fused cKIT D816V mutant (unknown origin) transfected in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by celltiter-glo/CCK8 assay, GI50 = 1.38 μM.	27077705
HT-29	Antiproliferative assay		72 hrs	Antiproliferative activity against human HT-29 cells after 72 hrs by MTT assay, IC50 = 1.47 μM.	23999040
HT-29	Antiproliferative assay		48 hrs	Antiproliferative activity against human HT-29 cells after 48 hrs by SRB assay, GI50 = 1.6 μM.	22560627
HT-29	Cytotoxicity assay			Cytotoxicity against human HT-29 cells by MTT assay, IC50 = 1.7 μM.	26920800
U937	Antiproliferative assay		72 hrs	Antiproliferative activity against human U937 cells assessed as reduction in cell viability after 72 hrs by celltiter-glo/CCK8 assay, GI50 = 1.7 μM.	27077705
MCF7	Antiproliferative assay		48 hrs	Antiproliferative activity against human MCF7 cells after 48 hrs by SRB assay, GI50 = 2 μM.	22560627
MDA-MB-435	Antiproliferative assay		48 hrs	Antiproliferative activity against human MDA-MB-435 cells after 48 hrs by SRB assay, GI50 = 2 μM.	22560627
GIST48B	Antiproliferative assay		72 hrs	Antiproliferative activity against human GIST48B cells assessed as reduction in cell viability after 72 hrs by celltiter-glo/CCK8 assay, GI50 = 2.01 μM.	27077705
CHO	Antiproliferative assay		72 hrs	Antiproliferative activity against CHO cells assessed as reduction in cell viability after 72 hrs by celltiter-glo/CCK8 assay, GI50 = 2.03 μM.	27077705
KB-3-1	Cytotoxicity assay		72 hrs	Cytotoxicity against human P-gp-negative KB-3-1 cells after 72 hrs by MTT assay, IC50 = 2.3 μM.	19397322
K562	Antitumor assay			Antitumor activity against human K562 cells, IC50 = 2.41 μM.	21450463
A549	Cytotoxicity assay		72 hrs	Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by MTT assay, IC50 = 2.44 μM.	23602441
T24	Antiproliferative assay		72 hrs	Antiproliferative activity against human T24 cells after 72 hrs by MTT assay, IC50 = 2.44 μM.	23999040
CHL	Antiproliferative assay		72 hrs	Antiproliferative activity against CHL cells assessed as reduction in cell viability after 72 hrs by celltiter-glo/CCK8 assay, GI50 = 2.48 μM.	27077705
ACHN	Cytotoxicity assay		6 days	Cytotoxicity against human ACHN cells assessed as inhibition of cell viability after 6 days by MTT assay, IC50 = 2.5 μM.	23360104
Bel7402	Antiproliferative assay		72 hrs	Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay, IC50 = 2.67 μM.	24904961
H460	Cytotoxicity assay		72 hrs	Cytotoxicity against human H460 cells assessed as cell growth inhibition after 72 hrs by MTT assay, IC50 = 2.7 μM.	21621880
BAF3	Antiproliferative assay			Antiproliferative activity against mouse BAF3 cells, GI50 = 2.78 μM.	27077705
HuH7	Antiproliferative assay			Antiproliferative activity against human HuH7 cells by MTT assay, IC50 = 3.03 μM.	30059803
HuH7	Growth inhibition assay		48 hrs	Growth inhibition of human HuH7 cells after 48 hrs by MTT assay, IC50 = 3.03 μM.	27956344
OVCAR3	Antiproliferative assay		48 hrs	Antiproliferative activity against human OVCAR3 cells after 48 hrs by SRB assay, GI50 = 3.2 μM.	22560627
HL60	Antitumor assay			Antitumor activity against human HL60 cells, IC50 = 3.53 μM.	21450463
BxPC3	Antiproliferative assay		72 hrs	Antiproliferative activity against human BxPC3 cells after 72 hrs by MTT assay, IC50 = 3.63 μM.	23999040
MDA-MB-231	Cytotoxicity assay		72 hrs	Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition after 72 hrs by MTT assay, IC50 = 3.7 μM.	21621880
HepG2	Antiproliferative assay		72 hrs	Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay, IC50 = 3.81 μM.	20570526
UACC257	Antiproliferative assay		48 hrs	Antiproliferative activity against human UACC257 cells after 48 hrs by SRB assay, GI50 = 4 μM.	22560627
RCC4	Anticancer assay		48 hrs	Anticancer activity against human RCC4 cells after 48 hrs by XTT assay, IC50 = 4 μM.	28325600
KBV1	Cytotoxicity assay		72 hrs	Cytotoxicity against human P-glycoprotein-expressing KBV1 cells after 72 hrs by MTT assay, IC50 = 4.1 μM.	19397322
A498	Cytotoxicity assay		72 hrs	Cytotoxicity against human A498 cells after 72 hrs by MTT assay, IC50 = 4.3 μM.	23489626
NCI-H460	Antiproliferative assay		72 hrs	Antiproliferative activity against human NCI-H460 cells after 72 hrs by MTT assay, IC50 = 4.31 μM.	24904961
MDA-MB-231	Antitumor assay			Antitumor activity against human MDA-MB-231 cells, IC50 = 4.51 μM.	21450463
L02	Cytotoxicity assay		72 hrs	Cytotoxicity against human L02 cells after 72 hrs by CCK-8 assay, IC50 = 4.62 μM.	27643639
HT-29	Cytotoxicity assay		48 hrs	Cytotoxicity against human HT-29 cells assessed as inhibition of cell viability after 48 hrs by SRB assay, IC50 = 4.7 μM.	26009164
HuH7	Antiproliferative assay		48 hrs	Antiproliferative activity against human HuH7 cells after 48 hrs by MTT assay, IC50 = 4.707 μM.	29057042
HCT116	Cytotoxicity assay		72 hrs	Cytotoxicity against human HCT116 cells assessed as growth inhibition after 72 hrs by MTT assay, IC50 = 4.71 μM.	23602441
BGC	Antiproliferative assay		72 hrs	Antiproliferative activity against human BGC cells after 72 hrs by MTT assay, IC50 = 4.78 μM.	23999040
BA/F3	Cytotoxicity assay		72 hrs	Cytotoxicity in mouse parental BA/F3 cells incubated for 72 hrs by MTS assay, GI50 = 4.789 μM.	30204441
HL60	Cytotoxicity assay		72 hrs	Cytotoxicity against human HL60 cells after 72 hrs by CCK-8 assay, IC50 = 4.95 μM.	27643639
A375	Toxicity against		72 hrs	Toxicity against human A375 cells after 72 hrs by cell titer-blue assay, IC50 = 5.4 μM.	19654408
HepG2	Antiproliferative assay		72 hrs	Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay, IC50 = 5.61 μM.	23999040
HCT116	Antiproliferative assay			Antiproliferative activity against human HCT116 cells by MTT assay, IC50 = 5.62 μM.	30059803
HCT116	Growth inhibition assay		48 hrs	Growth inhibition of human HCT116 cells after 48 hrs by MTT assay, IC50 = 5.62 μM.	27956344
ACHN	Cytotoxicity assay		72 hrs	Cytotoxicity against human ACHN cells after 72 hrs by MTT assay, IC50 = 5.7 μM.	23489626
HK2	Antiproliferative assay		72 hrs	Antiproliferative activity against human HK2 cells after 72 hrs by MTT assay, IC50 = 5.85 μM.	24904961
GISTT1	Cytotoxicity assay		72 hrs	Cytotoxicity against human GISTT1 cells harboring KIT D816E mutant assessed as cell growth inhibition after 72 hrs by CellTiterGlo assay, GI50 = 5.88 μM.	28991465
MDA-MB-231	Anticancer assay		48 hrs	Anticancer activity against human MDA-MB-231 cells after 48 hrs by XTT assay, IC50 = 6 μM.	28325600
HCT116	Cytotoxicity assay		48 hrs	Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay, IC50 = 6.1 μM.	22019188
HEK293	Function assay		2 mins	Inhibition of human OCT1 expressed in HEK293 cells assessed as decrease in uptake of ASP+ after 2 mins by fluorescence assay, IC50 = 6.1 μM.	28230985
SW620	Antiproliferative assay			Antiproliferative activity against human SW620 cells by MTT assay, IC50 = 6.25 μM.	30059803
SW620	Growth inhibition assay		48 hrs	Growth inhibition of human SW620 cells after 48 hrs by MTT assay, IC50 = 6.25 μM.	27956344
MCF7	Cytotoxicity assay		72 hrs	Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay, IC50 = 6.29 μM.	23602441
TK10	Antiproliferative assay		48 hrs	Antiproliferative activity against human TK10 cells after 48 hrs by SRB assay, GI50 = 6.3 μM.	22560627
SMMC7721	Cytotoxicity assay		72 hrs	Cytotoxicity against human SMMC7721 cells assessed as cell growth inhibition after 72 hrs by MTT assay, IC50 = 6.47 μM.	21621880
A549	Antitumor assay			Antitumor activity against human A549 cells, IC50 = 6.61 μM.	21450463
MDA-MB-231	Cytotoxicity assay		24 hrs	Cytotoxicity in human MDA-MB-231 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay, IC50 = 6.98 μM.	28760313
MDA-MB-231	Cytotoxicity assay		48 hrs	Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay, IC50 = 7.4 μM.	27128173
MDA-MB-231	Cytotoxicity assay		48 hrs	Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition after 48 hrs by MTT assay, IC50 = 7.4 μM.	27639369
MDA-MB-231	Cytotoxicity assay		48 hrs	Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 48 hrs by MTT assay, IC50 = 7.44 μM.	27448916
HepG2	Antiproliferative assay			Antiproliferative activity against human HepG2 cells by MTT assay, IC50 = 7.78 μM.	30059803
EKVX	Antiproliferative assay		48 hrs	Antiproliferative activity against human EKVX cells after 48 hrs by SRB assay, GI50 = 7.9 μM.	22560627
A549	Cytotoxicity assay		48 hrs	Cytotoxicity against human A549 cells assessed as inhibition of cell viability after 48 hrs by SRB assay, IC50 = 7.93 μM.	26009164
CHO	Function assay			Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) cells stable expressing hERG measured using IonWorks Barracuda automated patch clamp platform, IC50 = 7.94328 μM.	25087753
PA1	Cytotoxicity assay		48 hrs	Cytotoxicity against human PA1 cells assessed as decrease in cell viability after 48 hrs by MTT assay, IC50 = 7.97 μM.	27210438
A498	Antiproliferative assay		48 hrs	Antiproliferative activity against human A498 cells after 48 hrs by MTT assay, IC50 = 7.981 μM.	29057042
COLO205	Cytotoxicity assay		24 hrs	Cytotoxicity against human COLO205 cells after 24 hrs by MTT assay, IC50 = 8 μM.	28756024
SVEC4-10	Cytotoxicity assay		24 hrs	Cytotoxicity against mouse SVEC4-10 cells assessed as cell viability after 24 hrs by MTS assay, IC50 = 8 μM.	26912111
WI38	Cytotoxicity assay		72 hrs	Cytotoxicity against human WI38 cells assessed as cell growth inhibition after 72 hrs by MTT assay, IC50 = 8.56 μM.	21621880
A549	Cytotoxicity assay			Cytotoxicity against human A549 cells by MTT assay, IC50 = 9.1 μM.	26920800
SKOV3	Cytotoxicity assay		48 hrs	Cytotoxicity against human SKOV3 cells assessed as inhibition of cell viability after 48 hrs by SRB assay, IC50 = 9.21 μM.	26009164
MDA-MB-435	Cytotoxicity assay			Cytotoxicity against human MDA-MB-435 cells by MTT assay, IC50 = 9.3 μM.	26920800
SNB19	Antiproliferative assay		48 hrs	Antiproliferative activity against human SNB19 cells after 48 hrs by SRB assay, GI50 = 10 μM.	22560627
CHO K1	Function assay			Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform, IC50 = 10 μM.	25087753
NCI-H727	Antiproliferative assay		48 hrs	Antiproliferative activity against human NCI-H727 cells after 48 hrs by MTT assay, IC50 = 10.12 μM.	29057042
HeLa	Cytotoxicity assay		48 hrs	Cytotoxicity against human HeLa cells assessed as cell growth inhibition after 48 hrs by MTT assay, IC50 = 10.4 μM.	27639369
MCF7	Antiproliferative assay		48 hrs	Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay, IC50 = 10.5 μM.	25064347
PC9	Cytotoxicity assay		48 hrs	Cytotoxicity against human PC9 cells after 48 hrs by MTT assay, IC50 = 10.97 μM.	22483608
Bel7402	Photocytotoxicity assay		5 hrs	Photocytotoxicity against human Bel7402 cells assessed as cell viability preincubated for 5 hrs with cells followed by UVA-1 irradiation at 3.0 mW/cm'2 for 20 mins measured after 48 hrs by CCK8 assay, EC50 = 11 μM.	26584085
A375	Cytotoxicity assay		48 hrs	Cytotoxicity against human A375 cells after 48 hrs by MTT assay, IC50 = 11.58 μM.	22483608
SF539	Function assay		10 mins	Inhibition of PDGFRbeta phosphorylation in human SF539 cells after 10 mins by FLISA, IC50 = 12.2 μM.	20403700
A431	Function assay			Inhibition of PDGFRbeta expressed in human A431 cells, IC50 = 12.2 μM.	20558072
SF-539	Function assay		60 mins	Inhibition of PDGFRbeta tyrosine kinase activity in PDGF-BB-stimulated human SF-539 cells after 60 mins by ELISA, IC50 = 12.2 μM.	22204741
A549	Cytotoxicity assay		48 hrs	Cytotoxicity against human A549 cells after 48 hrs by MTT assay, IC50 = 12.35 μM.	22483608
PC3	Cytotoxicity assay		48 hrs	Cytotoxicity against human PC3 cells assessed as cell growth inhibition after 48 hrs by MTT assay, IC50 = 12.6 μM.	27639369
LNCAP	Cytotoxicity assay		48 hrs	Cytotoxicity against human LNCAP cells assessed as decrease in cell viability after 48 hrs by MTT assay, IC50 = 12.61 μM.	27210438
PANC1	Photocytotoxicity assay		5 hrs	Photocytotoxicity against human PANC1 cells assessed as cell viability preincubated for 5 hrs with cells followed by UVA-1 irradiation at 3.0 mW/cm'2 for 20 mins measured after 48 hrs by CCK8 assay, EC50 = 13 μM.	26584085
HepG2	Cytotoxicity assay		48 hrs	Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay, IC50 = 13.24 μM.	22483608
endothelial precursor cells	Function assay			Inhibition of cell migration in endothelial precursor cells by Oris cell migration kit based phenotypic drug discovery based assay, IC50 = 13.6 μM.	22409666
HepG2	Antiproliferative assay		48 hrs	Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay, IC50 = 13.6 μM.	25064347
K562	Cytotoxicity assay		24 hrs	Cytotoxicity against human K562 cells after 24 hrs by MTT assay, IC50 = 14 μM.	28756024
A549	Cytotoxicity assay		48 hrs	Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay, IC50 = 14.4 μM.	27448916
A549	Cytotoxicity assay		48 hrs	Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay, IC50 = 14.4 μM.	27639369
PANC1	Cytotoxicity assay		48 hrs	Cytotoxicity against human PANC1 cells assessed as inhibition of cell viability after 48 hrs by SRB assay, IC50 = 14.94 μM.	26009164
HepG2	Cytotoxicity assay		48 hrs	Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay, IC50 = 15.4 μM.	22019188
HL60	Cytotoxicity assay		48 hrs	Cytotoxicity against human HL60 cells after 48 hrs by MTT assay, IC50 = 15.5 μM.	22019188
BT549	Cytotoxicity assay		48 hrs	Cytotoxicity against human BT549 cells after 48 hrs by MTT assay, IC50 = 15.5 μM.	27128173
BT549	Cytotoxicity assay		48 hrs	Cytotoxicity against human BT549 cells assessed as cell growth inhibition after 48 hrs by MTT assay, IC50 = 15.5 μM.	27639369
BT549	Cytotoxicity assay		48 hrs	Cytotoxicity against human BT549 cells assessed as reduction in cell viability after 48 hrs by MTT assay, IC50 = 15.54 μM.	27448916
CHO K1	Function assay			Inhibition of fast sodium current (INa) in Chinese Hamster Ovary (CHO) K1 cells transfected with human Nav1.5 measured using IonWorks Quattro automated patch clamp platform, IC50 = 15.8489 μM.	25087753
HepG2	Antiproliferative assay		48 hrs	Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay, IC50 = 16.06 μM.	28057423
HepG2	Cytotoxicity assay		48 hrs	Cytotoxicity against human HepG2 cells assessed as inhibition of cell viability after 48 hrs by SRB assay, IC50 = 16.06 μM.	26009164
DU145	Cytotoxicity assay		48 hrs	Cytotoxicity against human DU145 cells assessed as cell growth inhibition after 48 hrs by MTT assay, IC50 = 16.3 μM.	27639369
DU145	Cytotoxicity assay		48 hrs	Cytotoxicity against human DU145 cells assessed as reduction in cell viability after 48 hrs by MTT assay, IC50 = 16.38 μM.	27448916
DU145	Cytotoxicity assay		48 hrs	Cytotoxicity against human DU145 cells after 48 hrs by MTT assay, IC50 = 16.4 μM.	27128173
HCT116	Cytotoxicity assay		48 hrs	Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay, IC50 = 18.35 μM.	22483608
A549	Cytotoxicity assay		48 hrs	Cytotoxicity against human A549 cells after 48 hrs by MTT assay, IC50 = 18.5 μM.	22019188
U251	Function assay		10 mins	Inhibition of VEGFR2 phosphorylation in human U251 cells after 10 mins by FLISA, IC50 = 18.9 μM.	20403700
A431	Function assay			Inhibition of VEGFR2 expressed in human A431 cells, IC50 = 18.9 μM.	20558072
U251	Function assay		60 mins	Inhibition of VEGFR2 tyrosine kinase activity in VEGF-stimulated human U251 cells after 60 mins by ELISA, IC50 = 18.9 μM.	22204741
U251	Function assay		60 mins	Inhibition of VEGF-induced VEGFR2 phosphorylation in human U251 cells overexpressing Flk-1 pretreated for 60 mins prior to VEGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis, IC50 = 18.9 μM.	23375090
U251	Function assay		60 mins	Inhibition of VEGFR2 in human U251 cells assessed as inhibition of VEGF-induced tyrosine phosphorylation incubated for 60 mins prior to VEGF-activation measured 10 mins by ELISA, IC50 = 18.9 μM.	23434139
U251	Function assay		60 mins	Inhibition of VEGFR2 in human U251 cells pretreated for 60 mins measured after 1 hr by ELISA, IC50 = 18.9 μM.	22739090
PC3	Cytotoxicity assay		48 hrs	Cytotoxicity against human PC3 cells after 48 hrs by MTT assay, IC50 = 19.6 μM.	27128173
PC3	Cytotoxicity assay		48 hrs	Cytotoxicity against human PC3 cells assessed as reduction in cell viability after 48 hrs by MTT assay, IC50 = 19.6 μM.	27448916
LO2	Antiproliferative assay		72 hrs	Antiproliferative activity against human LO2 cells after 72 hrs by MTT assay, IC50 = 19.93 μM.	24904961
K562	Cytotoxicity assay		48 hrs	Cytotoxicity against human K562 cells after 48 hrs by MTT assay, IC50 = 21.9 μM.	22019188
RWPE1	Cytotoxicity assay		48 hrs	Cytotoxicity against human RWPE1 cells assessed as decrease in cell viability after 48 hrs by MTT assay, IC50 = 23 μM.	27210438
RWPE1	Cytotoxicity assay		48 hrs	Cytotoxicity against human RWPE1 cells after 48 hrs by MTT assay, IC50 = 23 μM.	27128173
MCF7	Cytotoxicity assay		48 hrs	Cytotoxicity against human MCF7 cells assessed as decrease in cell viability after 48 hrs by MTT assay, IC50 = 23.76 μM.	27210438
MCF7	Cytotoxicity assay		48 hrs	Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay, IC50 = 23.8 μM.	27448916
PC3	Cytotoxicity assay		48 hrs	Cytotoxicity against human PC3 cells after 48 hrs by MTT assay, IC50 = 25.1 μM.	22019188
RWPE1	Cytotoxicity assay		48 hrs	Cytotoxicity against human RWPE1 cells assessed as cell growth inhibition after 48 hrs by MTT assay, IC50 = 25.2 μM.	27639369
MCF7	Antiproliferative assay		48 hrs	Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay, IC50 = 25.41 μM.	28057423
MCF7	Cytotoxicity assay		48 hrs	Cytotoxicity against human MCF7 cells assessed as inhibition of cell viability after 48 hrs by SRB assay, IC50 = 25.41 μM.	26009164
MDA-MB-231	Cytotoxicity assay		24 hrs	Cytotoxicity against human MDA-MB-231 cells after 24 hrs by MTT assay, IC50 = 32 μM.	28756024
CHO	Function assay			Inhibition of Cav1.2 current measured using QPatch automatic path clamp system in CHO cells expressing Cav1.2, beta-2 and alpha-2/delta-1 subunits, IC50 = 33.4 μM.	23812503
HEK293	Function assay			Inhibition of fast sodium current (INa) in HEK293 cells transfected with human Nav1.5 measured using IonWorks Quattro automated patch clamp platform, IC50 = 39.8107 μM.	25087753
H4	Toxicity assay	10 uM		Toxicity in human H4 cells at 10 uM, Activity = 40 μM.	20350806
MV4-11	Antitumor assay	30 mg/kg	28 days	Antitumor activity against human MV4-11 cells xenografted in athymic nude mouse assessed as suppression of tumor volume at 30 mg/kg, po QD for 28 days measured after dosing period	19754199
MV4-11	Antitumor assay	30 mg/kg	28 days	Antitumor activity against human MV4-11 cells xenografted in athymic nude mouse assessed as tumor growth regression at 30 mg/kg, po QD for 28 days measured after dosing period	19754199
MV4-11	Antitumor assay	30 mg/kg	28 days	Antitumor activity against human MV4-11 cells xenografted in athymic nude mouse assessed as inhibition of tumor growth at 30 mg/kg, po QD for 28 days measured during first 14 days of dosing	19754199
SK-RC-52	Antitumor assay	20 mg/kg		Antitumor activity against human SK-RC-52 cells xenografted BALB/c nu/nu mouse assessed as inhibition of tumor growth at 20 mg/kg, ip	19615903
MV411	Antitumor assay	10 mg/kg	28 days	Antitumor activity against human MV411 cells in xenografted athymic nude mouse model assessed as decrease in tumor size at 10 mg/kg, po qd for 28 days measured after 29 to 36 days	19646870
MV411	Antitumor assay	30 mg/kg	28 days	Antitumor activity against human MV411 cells in xenografted athymic nude mouse model assessed as decrease in tumor size at 30 mg/kg, po qd for 28 days	19646870
MV4-11	Antitumor assay	10 mg/kg		Antitumor activity against human MV4-11 cells xenografted mouse model assessed as inhibition of tumor growth at at 10 mg/kg, po	19654408
HEK293	Function assay	100 nM	1 hr	Inhibition of VEGF-induced autophosphorylation of tyrosine 1175 residue on VEGFR2 expressed in HEK293 cells at 100 nM after 1 hr by ELISA	21885287
Calu6	Antitumor assay	80 mg/kg	11 days	Antitumor activity against human Calu6 cells xenografted in BALB/c mouse assessed as tumor growth inhibition at 80 mg/kg, po qd for 11 days	22269278
BA/F3	Antitumor assay	0.05 to 5 mg/kg	100 days	Antitumor activity against mouse BA/F3 cells expressing FLT3-ITD mutant xenografted in BALB/c mouse myeloproliferative model assessed as disease related death at 0.05 to 5 mg/kg, po measured after 100 days	22221201
MDA-MB-435	Antiangiogenic assay	20 mg/kg	2 days	Antiangiogenic activity in human MDA-MB-435 cells xenografted in chicken embryo chorioallantoic membrane assessed as inhibition of blood vessel formation at 20 mg/kg measured after 2 days	23664876
MDA-MB-435	Antitumor assay	20 mg/kg	2 days	Antitumor activity against human MDA-MB-435 cells xenografted in chicken embryo chorioallantoic membrane assessed as inhibition of tumor volume at 20 mg/kg measured after 2 days	23664876
U251	Antitumor assay	30 mg/kg	up to 34 days	Antitumor activity against human U251 cells xenografted into athymic NCr mouse assessed as decrease in tumor growth at 30 mg/kg twice weekly measured up to 34 days	24900865
MDA-MB-435	Antitumor assay	30 mg/kg	up to 34 days	Antitumor activity against human MDA-MB-435 cells xenografted into flank of athymic BALBc/J mouse assessed as decrease in tumor growth at 30 mg/kg twice weekly measured up to 34 days	24900865
MDA-MB-435	Antitumor assay	30 mg/kg		Antitumor activity against human MDA-MB-435 cells xenografted into flank of athymic BALBc/J mouse assessed as decrease in tumor vascular density at 30 mg/kg twice weekly by CD31/PECAM-1 immunohistochemical staining	24900865
NCI-H460	Antitumor assay	40 mg/kg	up to 21 days	Antitumor activity against human NCI-H460 cells xenografted in BALB/c nude mouse assessed as tumor growth inhibition at 40 mg/kg/day administered qd measured up to day 21 relative to control	24904961
HT-29	Antitumor assay	40 mg/kg	up to 21 days	Antitumor activity against human HT-29 cells xenografted in BALB/c nude mouse assessed as tumor growth inhibition at 80 mg/kg/day administered qd measured up to day 21 relative to control	24904961
MCF7	Function assay	4 uM	24 hrs	Inhibition of VEGFR2 phosphorylation in human MCF7 cells at 4 uM incubated for 24 hrs by Western blot method	28942113
HUVEC	Antiangiogenic assay	10 uM	5 hrs	Antiangiogenic activity in human HUVEC cells assessed as angiogenesis rate at 10 uM after 5 hrs by endothelial tube formation assay relative to control	26912111
MCF7	Function assay	1 uM	24 hrs	Inhibition of VEGFR2 phosphorylation in human MCF7 cells assessed as reduction in expression of phosphorylated ERK1/2 at 1 uM incubated for 24 hrs by Western blot analysis	27176944
MCF7	Function assay	1 uM	24 hrs	Inhibition of VEGFR2 phosphorylation in human MCF7 cells assessed as reduction in expression of phosphorylated Raf1 at 1 uM incubated for 24 hrs by Western blot analysis	27176944
HCT116	Antimigratory assay		24 hrs	Antimigratory activity against human HCT116 cells assessed as inhibition of cell migration after 24 hrs by wound healing assay	23153200
U87MG	Function assay	10 mg/kg	3 days	In-vivo inhibition of angiogenesis in human U87MG cells xenografted in athymic nude Harlan mouse at 10 mg/kg oral gavage dosed twice daily for 3 days measured 3 days post dose by fluorescence microscopy	22409666
EoL-1-cell	Growth inhibition assay			Inhibition of human EoL-1-cell cell growth in a cell viability assay, IC50 = 0.0000016 μM.	SANGER
MV-4-11	Growth inhibition assay			Inhibition of human MV-4-11 cell growth in a cell viability assay, IC50 = 0.0002722 μM.	SANGER
NOS-1	Growth inhibition assay			Inhibition of human NOS-1 cell growth in a cell viability assay, IC50 = 0.0153 μM.	SANGER
CGTH-W-1	Growth inhibition assay			Inhibition of human CGTH-W-1 cell growth in a cell viability assay, IC50 = 0.03094 μM.	SANGER
MONO-MAC-6	Growth inhibition assay			Inhibition of human MONO-MAC-6 cell growth in a cell viability assay, IC50 = 0.0338 μM.	SANGER
ALL-PO	Growth inhibition assay			Inhibition of human ALL-PO cell growth in a cell viability assay, IC50 = 0.07989 μM.	SANGER
NKM-1	Growth inhibition assay			Inhibition of human NKM-1 cell growth in a cell viability assay, IC50 = 0.09852 μM.	SANGER
KM12	Growth inhibition assay			Inhibition of human KM12 cell growth in a cell viability assay, IC50 = 0.35014 μM.	SANGER
TE-15	Growth inhibition assay			Inhibition of human TE-15 cell growth in a cell viability assay, IC50 = 0.50761 μM.	SANGER
697	Growth inhibition assay			Inhibition of human 697 cell growth in a cell viability assay, IC50 = 0.61425 μM.	SANGER
MOLT-16	Growth inhibition assay			Inhibition of human MOLT-16 cell growth in a cell viability assay, IC50 = 0.63132 μM.	SANGER
GB-1	Growth inhibition assay			Inhibition of human GB-1 cell growth in a cell viability assay, IC50 = 0.71023 μM.	SANGER
TE-12	Growth inhibition assay			Inhibition of human TE-12 cell growth in a cell viability assay, IC50 = 0.80455 μM.	SANGER
ES6	Growth inhibition assay			Inhibition of human ES6 cell growth in a cell viability assay, IC50 = 0.98106 μM.	SANGER
LC-2-ad	Growth inhibition assay			Inhibition of human LC-2-ad cell growth in a cell viability assay, IC50 = 1.11407 μM.	SANGER
BL-70	Growth inhibition assay			Inhibition of human BL-70 cell growth in a cell viability assay, IC50 = 1.11846 μM.	SANGER
ETK-1	Growth inhibition assay			Inhibition of human ETK-1 cell growth in a cell viability assay, IC50 = 1.2858 μM.	SANGER
A4-Fuk	Growth inhibition assay			Inhibition of human A4-Fuk cell growth in a cell viability assay, IC50 = 1.34141 μM.	SANGER
OCI-AML2	Growth inhibition assay			Inhibition of human OCI-AML2 cell growth in a cell viability assay, IC50 = 1.36851 μM.	SANGER
SIG-M5	Growth inhibition assay			Inhibition of human SIG-M5 cell growth in a cell viability assay, IC50 = 1.37009 μM.	SANGER
NCI-SNU-16	Growth inhibition assay			Inhibition of human NCI-SNU-16 cell growth in a cell viability assay, IC50 = 1.46486 μM.	SANGER
PSN1	Growth inhibition assay			Inhibition of human PSN1 cell growth in a cell viability assay, IC50 = 1.50676 μM.	SANGER
SR	Growth inhibition assay			Inhibition of human SR cell growth in a cell viability assay, IC50 = 1.54572 μM.	SANGER
A3-KAW	Growth inhibition assay			Inhibition of human A3-KAW cell growth in a cell viability assay, IC50 = 1.62546 μM.	SANGER
KS-1	Growth inhibition assay			Inhibition of human KS-1 cell growth in a cell viability assay, IC50 = 1.69247 μM.	SANGER
CTV-1	Growth inhibition assay			Inhibition of human CTV-1 cell growth in a cell viability assay, IC50 = 1.72751 μM.	SANGER
LB1047-RCC	Growth inhibition assay			Inhibition of human LB1047-RCC cell growth in a cell viability assay, IC50 = 1.81624 μM.	SANGER
MEG-01	Growth inhibition assay			Inhibition of human MEG-01 cell growth in a cell viability assay, IC50 = 1.83563 μM.	SANGER
TE-11	Growth inhibition assay			Inhibition of human TE-11 cell growth in a cell viability assay, IC50 = 1.83985 μM.	SANGER
CMK	Growth inhibition assay			Inhibition of human CMK cell growth in a cell viability assay, IC50 = 1.95517 μM.	SANGER
NB1	Growth inhibition assay			Inhibition of human NB1 cell growth in a cell viability assay, IC50 = 1.96117 μM.	SANGER
HAL-01	Growth inhibition assay			Inhibition of human HAL-01 cell growth in a cell viability assay, IC50 = 2.05946 μM.	SANGER
DEL	Growth inhibition assay			Inhibition of human DEL cell growth in a cell viability assay, IC50 = 2.08482 μM.	SANGER
RL95-2	Growth inhibition assay			Inhibition of human RL95-2 cell growth in a cell viability assay, IC50 = 2.11137 μM.	SANGER
KARPAS-299	Growth inhibition assay			Inhibition of human KARPAS-299 cell growth in a cell viability assay, IC50 = 2.11313 μM.	SANGER
EW-16	Growth inhibition assay			Inhibition of human EW-16 cell growth in a cell viability assay, IC50 = 2.13508 μM.	SANGER
RS4-11	Growth inhibition assay			Inhibition of human RS4-11 cell growth in a cell viability assay, IC50 = 2.17924 μM.	SANGER
BB30-HNC	Growth inhibition assay			Inhibition of human BB30-HNC cell growth in a cell viability assay, IC50 = 2.22375 μM.	SANGER
DOHH-2	Growth inhibition assay			Inhibition of human DOHH-2 cell growth in a cell viability assay, IC50 = 2.33431 μM.	SANGER
RPMI-8402	Growth inhibition assay			Inhibition of human RPMI-8402 cell growth in a cell viability assay, IC50 = 2.33618 μM.	SANGER
BV-173	Growth inhibition assay			Inhibition of human BV-173 cell growth in a cell viability assay, IC50 = 2.3366 μM.	SANGER
TE-10	Growth inhibition assay			Inhibition of human TE-10 cell growth in a cell viability assay, IC50 = 2.34384 μM.	SANGER
TE-8	Growth inhibition assay			Inhibition of human TE-8 cell growth in a cell viability assay, IC50 = 2.37038 μM.	SANGER
K052	Growth inhibition assay			Inhibition of human K052 cell growth in a cell viability assay, IC50 = 2.40202 μM.	SANGER
KARPAS-45	Growth inhibition assay			Inhibition of human KARPAS-45 cell growth in a cell viability assay, IC50 = 2.49446 μM.	SANGER
SK-NEP-1	Growth inhibition assay			Inhibition of human SK-NEP-1 cell growth in a cell viability assay, IC50 = 2.60237 μM.	SANGER
KGN	Growth inhibition assay			Inhibition of human KGN cell growth in a cell viability assay, IC50 = 2.60339 μM.	SANGER
ML-2	Growth inhibition assay			Inhibition of human ML-2 cell growth in a cell viability assay, IC50 = 2.63512 μM.	SANGER
LAMA-84	Growth inhibition assay			Inhibition of human LAMA-84 cell growth in a cell viability assay, IC50 = 2.69545 μM.	SANGER
LXF-289	Growth inhibition assay			Inhibition of human LXF-289 cell growth in a cell viability assay, IC50 = 2.72989 μM.	SANGER
A101D	Growth inhibition assay			Inhibition of human A101D cell growth in a cell viability assay, IC50 = 2.78304 μM.	SANGER
KY821	Growth inhibition assay			Inhibition of human KY821 cell growth in a cell viability assay, IC50 = 2.79758 μM.	SANGER
ES4	Growth inhibition assay			Inhibition of human ES4 cell growth in a cell viability assay, IC50 = 2.80628 μM.	SANGER
SCC-3	Growth inhibition assay			Inhibition of human SCC-3 cell growth in a cell viability assay, IC50 = 2.82891 μM.	SANGER
NALM-6	Growth inhibition assay			Inhibition of human NALM-6 cell growth in a cell viability assay, IC50 = 2.90473 μM.	SANGER
BL-41	Growth inhibition assay			Inhibition of human BL-41 cell growth in a cell viability assay, IC50 = 2.91222 μM.	SANGER
OPM-2	Growth inhibition assay			Inhibition of human OPM-2 cell growth in a cell viability assay, IC50 = 3.05954 μM.	SANGER
SF126	Growth inhibition assay			Inhibition of human SF126 cell growth in a cell viability assay, IC50 = 3.06198 μM.	SANGER
BE-13	Growth inhibition assay			Inhibition of human BE-13 cell growth in a cell viability assay, IC50 = 3.23111 μM.	SANGER
SF268	Growth inhibition assay			Inhibition of human SF268 cell growth in a cell viability assay, IC50 = 3.32869 μM.	SANGER
MOLT-4	Growth inhibition assay			Inhibition of human MOLT-4 cell growth in a cell viability assay, IC50 = 3.39838 μM.	SANGER
PF-382	Growth inhibition assay			Inhibition of human PF-382 cell growth in a cell viability assay, IC50 = 3.4457 μM.	SANGER
HEL	Growth inhibition assay			Inhibition of human HEL cell growth in a cell viability assay, IC50 = 3.48005 μM.	SANGER
RPMI-6666	Growth inhibition assay			Inhibition of human RPMI-6666 cell growth in a cell viability assay, IC50 = 3.54171 μM.	SANGER
QIMR-WIL	Growth inhibition assay			Inhibition of human QIMR-WIL cell growth in a cell viability assay, IC50 = 3.63391 μM.	SANGER
ATN-1	Growth inhibition assay			Inhibition of human ATN-1 cell growth in a cell viability assay, IC50 = 3.67114 μM.	SANGER
BB49-HNC	Growth inhibition assay			Inhibition of human BB49-HNC cell growth in a cell viability assay, IC50 = 3.70508 μM.	SANGER
HCE-4	Growth inhibition assay			Inhibition of human HCE-4 cell growth in a cell viability assay, IC50 = 3.78642 μM.	SANGER
SK-LMS-1	Growth inhibition assay			Inhibition of human SK-LMS-1 cell growth in a cell viability assay, IC50 = 3.83338 μM.	SANGER
MS-1	Growth inhibition assay			Inhibition of human MS-1 cell growth in a cell viability assay, IC50 = 3.83778 μM.	SANGER
JAR	Growth inhibition assay			Inhibition of human JAR cell growth in a cell viability assay, IC50 = 3.98832 μM.	SANGER
KE-37	Growth inhibition assay			Inhibition of human KE-37 cell growth in a cell viability assay, IC50 = 4.06158 μM.	SANGER
LB996-RCC	Growth inhibition assay			Inhibition of human LB996-RCC cell growth in a cell viability assay, IC50 = 4.12168 μM.	SANGER
HH	Growth inhibition assay			Inhibition of human HH cell growth in a cell viability assay, IC50 = 4.20914 μM.	SANGER
HL-60	Growth inhibition assay			Inhibition of human HL-60 cell growth in a cell viability assay, IC50 = 4.21065 μM.	SANGER
HOP-62	Growth inhibition assay			Inhibition of human HOP-62 cell growth in a cell viability assay, IC50 = 4.3352 μM.	SANGER
NOMO-1	Growth inhibition assay			Inhibition of human NOMO-1 cell growth in a cell viability assay, IC50 = 4.33699 μM.	SANGER
DU-4475	Growth inhibition assay			Inhibition of human DU-4475 cell growth in a cell viability assay, IC50 = 4.36729 μM.	SANGER
LC4-1	Growth inhibition assay			Inhibition of human LC4-1 cell growth in a cell viability assay, IC50 = 4.3807 μM.	SANGER
MC116	Growth inhibition assay			Inhibition of human MC116 cell growth in a cell viability assay, IC50 = 4.43081 μM.	SANGER
SW982	Growth inhibition assay			Inhibition of human SW982 cell growth in a cell viability assay, IC50 = 4.55307 μM.	SANGER
SK-N-DZ	Growth inhibition assay			Inhibition of human SK-N-DZ cell growth in a cell viability assay, IC50 = 4.67099 μM.	SANGER
EW-1	Growth inhibition assay			Inhibition of human EW-1 cell growth in a cell viability assay, IC50 = 4.67911 μM.	SANGER
SU-DHL-1	Growth inhibition assay			Inhibition of human SU-DHL-1 cell growth in a cell viability assay, IC50 = 4.80174 μM.	SANGER
L-363	Growth inhibition assay			Inhibition of human L-363 cell growth in a cell viability assay, IC50 = 4.80621 μM.	SANGER
OS-RC-2	Growth inhibition assay			Inhibition of human OS-RC-2 cell growth in a cell viability assay, IC50 = 4.8731 μM.	SANGER
HD-MY-Z	Growth inhibition assay			Inhibition of human HD-MY-Z cell growth in a cell viability assay, IC50 = 5.17301 μM.	SANGER
MHH-PREB-1	Growth inhibition assay			Inhibition of human MHH-PREB-1 cell growth in a cell viability assay, IC50 = 5.32312 μM.	SANGER
HC-1	Growth inhibition assay			Inhibition of human HC-1 cell growth in a cell viability assay, IC50 = 5.43291 μM.	SANGER
SK-MM-2	Growth inhibition assay			Inhibition of human SK-MM-2 cell growth in a cell viability assay, IC50 = 5.4782 μM.	SANGER
SH-4	Growth inhibition assay			Inhibition of human SH-4 cell growth in a cell viability assay, IC50 = 5.4837 μM.	SANGER
MHH-CALL-2	Growth inhibition assay			Inhibition of human MHH-CALL-2 cell growth in a cell viability assay, IC50 = 5.76719 μM.	SANGER
KG-1	Growth inhibition assay			Inhibition of human KG-1 cell growth in a cell viability assay, IC50 = 6.02878 μM.	SANGER
J-RT3-T3-5	Growth inhibition assay			Inhibition of human J-RT3-T3-5 cell growth in a cell viability assay, IC50 = 6.07909 μM.	SANGER
MMAC-SF	Growth inhibition assay			Inhibition of human MMAC-SF cell growth in a cell viability assay, IC50 = 6.10949 μM.	SANGER
IST-SL2	Growth inhibition assay			Inhibition of human IST-SL2 cell growth in a cell viability assay, IC50 = 6.12519 μM.	SANGER
SW954	Growth inhibition assay			Inhibition of human SW954 cell growth in a cell viability assay, IC50 = 6.27517 μM.	SANGER
HDLM-2	Growth inhibition assay			Inhibition of human HDLM-2 cell growth in a cell viability assay, IC50 = 6.32109 μM.	SANGER
ST486	Growth inhibition assay			Inhibition of human ST486 cell growth in a cell viability assay, IC50 = 6.3471 μM.	SANGER
DG-75	Growth inhibition assay			Inhibition of human DG-75 cell growth in a cell viability assay, IC50 = 6.43069 μM.	SANGER
EW-3	Growth inhibition assay			Inhibition of human EW-3 cell growth in a cell viability assay, IC50 = 6.43207 μM.	SANGER
8-MG-BA	Growth inhibition assay			Inhibition of human 8-MG-BA cell growth in a cell viability assay, IC50 = 6.51507 μM.	SANGER
GT3TKB	Growth inhibition assay			Inhibition of human GT3TKB cell growth in a cell viability assay, IC50 = 6.60763 μM.	SANGER
KU812	Growth inhibition assay			Inhibition of human KU812 cell growth in a cell viability assay, IC50 = 6.6942 μM.	SANGER
CESS	Growth inhibition assay			Inhibition of human CESS cell growth in a cell viability assay, IC50 = 7.10438 μM.	SANGER
BC-1	Growth inhibition assay			Inhibition of human BC-1 cell growth in a cell viability assay, IC50 = 7.24812 μM.	SANGER
MZ1-PC	Growth inhibition assay			Inhibition of human MZ1-PC cell growth in a cell viability assay, IC50 = 7.30389 μM.	SANGER
NCI-H82	Growth inhibition assay			Inhibition of human NCI-H82 cell growth in a cell viability assay, IC50 = 7.3785 μM.	SANGER
NCI-H1355	Growth inhibition assay			Inhibition of human NCI-H1355 cell growth in a cell viability assay, IC50 = 7.45804 μM.	SANGER
RPMI-8226	Growth inhibition assay			Inhibition of human RPMI-8226 cell growth in a cell viability assay, IC50 = 7.50739 μM.	SANGER
ARH-77	Growth inhibition assay			Inhibition of human ARH-77 cell growth in a cell viability assay, IC50 = 7.53597 μM.	SANGER
MN-60	Growth inhibition assay			Inhibition of human MN-60 cell growth in a cell viability assay, IC50 = 7.54088 μM.	SANGER
IMR-5	Growth inhibition assay			Inhibition of human IMR-5 cell growth in a cell viability assay, IC50 = 7.54876 μM.	SANGER
KARPAS-422	Growth inhibition assay			Inhibition of human KARPAS-422 cell growth in a cell viability assay, IC50 = 7.57206 μM.	SANGER
CA46	Growth inhibition assay			Inhibition of human CA46 cell growth in a cell viability assay, IC50 = 7.58012 μM.	SANGER
SJSA-1	Growth inhibition assay			Inhibition of human SJSA-1 cell growth in a cell viability assay, IC50 = 7.66061 μM.	SANGER
no-11	Growth inhibition assay			Inhibition of human no-11 cell growth in a cell viability assay, IC50 = 7.77557 μM.	SANGER
IST-SL1	Growth inhibition assay			Inhibition of human IST-SL1 cell growth in a cell viability assay, IC50 = 8.02417 μM.	SANGER
NCI-H209	Growth inhibition assay			Inhibition of human NCI-H209 cell growth in a cell viability assay, IC50 = 8.11652 μM.	SANGER
TALL-1	Growth inhibition assay			Inhibition of human TALL-1 cell growth in a cell viability assay, IC50 = 8.18384 μM.	SANGER
KMOE-2	Growth inhibition assay			Inhibition of human KMOE-2 cell growth in a cell viability assay, IC50 = 8.1942 μM.	SANGER
HCC1599	Growth inhibition assay			Inhibition of human HCC1599 cell growth in a cell viability assay, IC50 = 8.19987 μM.	SANGER
GI-1	Growth inhibition assay			Inhibition of human GI-1 cell growth in a cell viability assay, IC50 = 8.20411 μM.	SANGER
NCI-H1304	Growth inhibition assay			Inhibition of human NCI-H1304 cell growth in a cell viability assay, IC50 = 8.20661 μM.	SANGER
Daudi	Growth inhibition assay			Inhibition of human Daudi cell growth in a cell viability assay, IC50 = 8.23546 μM.	SANGER
CPC-N	Growth inhibition assay			Inhibition of human CPC-N cell growth in a cell viability assay, IC50 = 8.29199 μM.	SANGER
MC-CAR	Growth inhibition assay			Inhibition of human MC-CAR cell growth in a cell viability assay, IC50 = 8.3358 μM.	SANGER
SW872	Growth inhibition assay			Inhibition of human SW872 cell growth in a cell viability assay, IC50 = 8.34758 μM.	SANGER
OVCAR-4	Growth inhibition assay			Inhibition of human OVCAR-4 cell growth in a cell viability assay, IC50 = 8.50351 μM.	SANGER
OCUB-M	Growth inhibition assay			Inhibition of human OCUB-M cell growth in a cell viability assay, IC50 = 8.56508 μM.	SANGER
SK-PN-DW	Growth inhibition assay			Inhibition of human SK-PN-DW cell growth in a cell viability assay, IC50 = 8.60985 μM.	SANGER
NCCIT	Growth inhibition assay			Inhibition of human NCCIT cell growth in a cell viability assay, IC50 = 8.71745 μM.	SANGER
NCI-H1648	Growth inhibition assay			Inhibition of human NCI-H1648 cell growth in a cell viability assay, IC50 = 9.13834 μM.	SANGER
COR-L279	Growth inhibition assay			Inhibition of human COR-L279 cell growth in a cell viability assay, IC50 = 9.3909 μM.	SANGER
LS-123	Growth inhibition assay			Inhibition of human LS-123 cell growth in a cell viability assay, IC50 = 9.68161 μM.	SANGER
LP-1	Growth inhibition assay			Inhibition of human LP-1 cell growth in a cell viability assay, IC50 = 9.78083 μM.	SANGER
NB13	Growth inhibition assay			Inhibition of human NB13 cell growth in a cell viability assay, IC50 = 9.79994 μM.	SANGER
ONS-76	Growth inhibition assay			Inhibition of human ONS-76 cell growth in a cell viability assay, IC50 = 9.81016 μM.	SANGER
VA-ES-BJ	Growth inhibition assay			Inhibition of human VA-ES-BJ cell growth in a cell viability assay, IC50 = 9.99933 μM.	SANGER
GR-ST	Growth inhibition assay			Inhibition of human GR-ST cell growth in a cell viability assay, IC50 = 10.2207 μM.	SANGER
ES1	Growth inhibition assay			Inhibition of human ES1 cell growth in a cell viability assay, IC50 = 10.2984 μM.	SANGER
NB14	Growth inhibition assay			Inhibition of human NB14 cell growth in a cell viability assay, IC50 = 10.9276 μM.	SANGER
Ramos-2G6-4C10	Growth inhibition assay			Inhibition of human Ramos-2G6-4C10 cell growth in a cell viability assay, IC50 = 11.265 μM.	SANGER
RXF393	Growth inhibition assay			Inhibition of human RXF393 cell growth in a cell viability assay, IC50 = 11.4834 μM.	SANGER
NCI-H2107	Growth inhibition assay			Inhibition of human NCI-H2107 cell growth in a cell viability assay, IC50 = 11.5984 μM.	SANGER
K-562	Growth inhibition assay			Inhibition of human K-562 cell growth in a cell viability assay, IC50 = 11.8702 μM.	SANGER
LOUCY	Growth inhibition assay			Inhibition of human LOUCY cell growth in a cell viability assay, IC50 = 11.9875 μM.	SANGER
TGBC1TKB	Growth inhibition assay			Inhibition of human TGBC1TKB cell growth in a cell viability assay, IC50 = 12.002 μM.	SANGER
COLO-320-HSR	Growth inhibition assay			Inhibition of human COLO-320-HSR cell growth in a cell viability assay, IC50 = 12.1565 μM.	SANGER
K5	Growth inhibition assay			Inhibition of human K5 cell growth in a cell viability assay, IC50 = 12.2985 μM.	SANGER
BC-3	Growth inhibition assay			Inhibition of human BC-3 cell growth in a cell viability assay, IC50 = 12.4651 μM.	SANGER
REH	Growth inhibition assay			Inhibition of human REH cell growth in a cell viability assay, IC50 = 12.6498 μM.	SANGER
NEC8	Growth inhibition assay			Inhibition of human NEC8 cell growth in a cell viability assay, IC50 = 12.6887 μM.	SANGER
IST-MEL1	Growth inhibition assay			Inhibition of human IST-MEL1 cell growth in a cell viability assay, IC50 = 12.8695 μM.	SANGER
NCI-H128	Growth inhibition assay			Inhibition of human NCI-H128 cell growth in a cell viability assay, IC50 = 13.0723 μM.	SANGER
NCI-H1694	Growth inhibition assay			Inhibition of human NCI-H1694 cell growth in a cell viability assay, IC50 = 13.1144 μM.	SANGER
TGW	Growth inhibition assay			Inhibition of human TGW cell growth in a cell viability assay, IC50 = 13.3276 μM.	SANGER
NCI-SNU-1	Growth inhibition assay			Inhibition of human NCI-SNU-1 cell growth in a cell viability assay, IC50 = 13.345 μM.	SANGER
IST-MES1	Growth inhibition assay			Inhibition of human IST-MES1 cell growth in a cell viability assay, IC50 = 13.6729 μM.	SANGER
CTB-1	Growth inhibition assay			Inhibition of human CTB-1 cell growth in a cell viability assay, IC50 = 13.7294 μM.	SANGER
HUTU-80	Growth inhibition assay			Inhibition of human HUTU-80 cell growth in a cell viability assay, IC50 = 13.7573 μM.	SANGER
LAN-6	Growth inhibition assay			Inhibition of human LAN-6 cell growth in a cell viability assay, IC50 = 14.2457 μM.	SANGER
KP-N-YS	Growth inhibition assay			Inhibition of human KP-N-YS cell growth in a cell viability assay, IC50 = 14.2894 μM.	SANGER
CCRF-CEM	Growth inhibition assay			Inhibition of human CCRF-CEM cell growth in a cell viability assay, IC50 = 14.4169 μM.	SANGER
NCI-H1770	Growth inhibition assay			Inhibition of human NCI-H1770 cell growth in a cell viability assay, IC50 = 14.5369 μM.	SANGER
MZ2-MEL	Growth inhibition assay			Inhibition of human MZ2-MEL cell growth in a cell viability assay, IC50 = 15.2251 μM.	SANGER
COR-L88	Growth inhibition assay			Inhibition of human COR-L88 cell growth in a cell viability assay, IC50 = 16.0012 μM.	SANGER
LOXIMVI	Growth inhibition assay			Inhibition of human LOXIMVI cell growth in a cell viability assay, IC50 = 16.256 μM.	SANGER
KALS-1	Growth inhibition assay			Inhibition of human KALS-1 cell growth in a cell viability assay, IC50 = 16.5931 μM.	SANGER
D-283MED	Growth inhibition assay			Inhibition of human D-283MED cell growth in a cell viability assay, IC50 = 16.8489 μM.	SANGER
NCI-H719	Growth inhibition assay			Inhibition of human NCI-H719 cell growth in a cell viability assay, IC50 = 16.9161 μM.	SANGER
MLMA	Growth inhibition assay			Inhibition of human MLMA cell growth in a cell viability assay, IC50 = 16.9907 μM.	SANGER
EVSA-T	Growth inhibition assay			Inhibition of human EVSA-T cell growth in a cell viability assay, IC50 = 17.0485 μM.	SANGER
SK-N-FI	Growth inhibition assay			Inhibition of human SK-N-FI cell growth in a cell viability assay, IC50 = 17.6913 μM.	SANGER
NTERA-S-cl-D1	Growth inhibition assay			Inhibition of human NTERA-S-cl-D1 cell growth in a cell viability assay, IC50 = 17.8572 μM.	SANGER
NCI-H1882	Growth inhibition assay			Inhibition of human NCI-H1882 cell growth in a cell viability assay, IC50 = 17.9834 μM.	SANGER
A704	Growth inhibition assay			Inhibition of human A704 cell growth in a cell viability assay, IC50 = 17.9904 μM.	SANGER
L-428	Growth inhibition assay			Inhibition of human L-428 cell growth in a cell viability assay, IC50 = 18.0151 μM.	SANGER
HCC1187	Growth inhibition assay			Inhibition of human HCC1187 cell growth in a cell viability assay, IC50 = 18.0188 μM.	SANGER
NCI-H1581	Growth inhibition assay			Inhibition of human NCI-H1581 cell growth in a cell viability assay, IC50 = 18.0866 μM.	SANGER
BB65-RCC	Growth inhibition assay			Inhibition of human BB65-RCC cell growth in a cell viability assay, IC50 = 18.4162 μM.	SANGER
EM-2	Growth inhibition assay			Inhibition of human EM-2 cell growth in a cell viability assay, IC50 = 18.5672 μM.	SANGER
Raji	Growth inhibition assay			Inhibition of human Raji cell growth in a cell viability assay, IC50 = 19.9565 μM.	SANGER
TE-1	Growth inhibition assay			Inhibition of human TE-1 cell growth in a cell viability assay, IC50 = 20.4104 μM.	SANGER
SW962	Growth inhibition assay			Inhibition of human SW962 cell growth in a cell viability assay, IC50 = 20.4293 μM.	SANGER
MHH-NB-11	Growth inhibition assay			Inhibition of human MHH-NB-11 cell growth in a cell viability assay, IC50 = 20.5521 μM.	SANGER
no-10	Growth inhibition assay			Inhibition of human no-10 cell growth in a cell viability assay, IC50 = 21.0265 μM.	SANGER
GDM-1	Growth inhibition assay			Inhibition of human GDM-1 cell growth in a cell viability assay, IC50 = 21.9414 μM.	SANGER
KMS-12-PE	Growth inhibition assay			Inhibition of human KMS-12-PE cell growth in a cell viability assay, IC50 = 22.2739 μM.	SANGER
NCI-H510A	Growth inhibition assay			Inhibition of human NCI-H510A cell growth in a cell viability assay, IC50 = 24.1278 μM.	SANGER
ES5	Growth inhibition assay			Inhibition of human ES5 cell growth in a cell viability assay, IC50 = 24.7349 μM.	SANGER
JiyoyeP-2003	Growth inhibition assay			Inhibition of human JiyoyeP-2003 cell growth in a cell viability assay, IC50 = 26.2742 μM.	SANGER
NMC-G1	Growth inhibition assay			Inhibition of human NMC-G1 cell growth in a cell viability assay, IC50 = 27.1822 μM.	SANGER
NCI-H446	Growth inhibition assay			Inhibition of human NCI-H446 cell growth in a cell viability assay, IC50 = 27.4946 μM.	SANGER
NB7	Growth inhibition assay			Inhibition of human NB7 cell growth in a cell viability assay, IC50 = 27.9229 μM.	SANGER
A388	Growth inhibition assay			Inhibition of human A388 cell growth in a cell viability assay, IC50 = 28.0073 μM.	SANGER
JVM-2	Growth inhibition assay			Inhibition of human JVM-2 cell growth in a cell viability assay, IC50 = 28.2898 μM.	SANGER
HT-144	Growth inhibition assay			Inhibition of human HT-144 cell growth in a cell viability assay, IC50 = 28.6899 μM.	SANGER
NCI-H747	Growth inhibition assay			Inhibition of human NCI-H747 cell growth in a cell viability assay, IC50 = 28.9195 μM.	SANGER
NCI-H1650	Growth inhibition assay			Inhibition of human NCI-H1650 cell growth in a cell viability assay, IC50 = 29.0176 μM.	SANGER
EB-3	Growth inhibition assay			Inhibition of human EB-3 cell growth in a cell viability assay, IC50 = 29.5309 μM.	SANGER
KLE	Growth inhibition assay			Inhibition of human KLE cell growth in a cell viability assay, IC50 = 29.619 μM.	SANGER
TK10	Growth inhibition assay			Inhibition of human TK10 cell growth in a cell viability assay, IC50 = 30.126 μM.	SANGER
COLO-668	Growth inhibition assay			Inhibition of human COLO-668 cell growth in a cell viability assay, IC50 = 30.792 μM.	SANGER
NCI-H23	Growth inhibition assay			Inhibition of human NCI-H23 cell growth in a cell viability assay, IC50 = 31.1063 μM.	SANGER
GOTO	Growth inhibition assay			Inhibition of human GOTO cell growth in a cell viability assay, IC50 = 31.6085 μM.	SANGER
MSTO-211H	Growth inhibition assay			Inhibition of human MSTO-211H cell growth in a cell viability assay, IC50 = 31.8678 μM.	SANGER
LB831-BLC	Growth inhibition assay			Inhibition of human LB831-BLC cell growth in a cell viability assay, IC50 = 32.3843 μM.	SANGER
SCH	Growth inhibition assay			Inhibition of human SCH cell growth in a cell viability assay, IC50 = 32.8485 μM.	SANGER
EHEB	Growth inhibition assay			Inhibition of human EHEB cell growth in a cell viability assay, IC50 = 34.1193 μM.	SANGER
U-266	Growth inhibition assay			Inhibition of human U-266 cell growth in a cell viability assay, IC50 = 34.2782 μM.	SANGER
EW-11	Growth inhibition assay			Inhibition of human EW-11 cell growth in a cell viability assay, IC50 = 34.4725 μM.	SANGER
TE-9	Growth inhibition assay			Inhibition of human TE-9 cell growth in a cell viability assay, IC50 = 37.0401 μM.	SANGER
ES3	Growth inhibition assay			Inhibition of human ES3 cell growth in a cell viability assay, IC50 = 37.5004 μM.	SANGER
NCI-H2141	Growth inhibition assay			Inhibition of human NCI-H2141 cell growth in a cell viability assay, IC50 = 38.0843 μM.	SANGER
MPP-89	Growth inhibition assay			Inhibition of human MPP-89 cell growth in a cell viability assay, IC50 = 42.0586 μM.	SANGER
SK-MEL-2	Growth inhibition assay			Inhibition of human SK-MEL-2 cell growth in a cell viability assay, IC50 = 42.6405 μM.	SANGER
LC-1F	Growth inhibition assay			Inhibition of human LC-1F cell growth in a cell viability assay, IC50 = 43.3682 μM.	SANGER
NH-12	Growth inhibition assay			Inhibition of human NH-12 cell growth in a cell viability assay, IC50 = 43.9359 μM.	SANGER
RKO	Growth inhibition assay			Inhibition of human RKO cell growth in a cell viability assay, IC50 = 44.1252 μM.	SANGER
KM-H2	Growth inhibition assay			Inhibition of human KM-H2 cell growth in a cell viability assay, IC50 = 44.9577 μM.	SANGER
SK-UT-1	Growth inhibition assay			Inhibition of human SK-UT-1 cell growth in a cell viability assay, IC50 = 49.8825 μM.	SANGER
클릭하여 더 많은 세포주 실험 데이터 보기

화학 정보, 보관 및 안정성

분자량	398.47	화학식	C₂₂H₂₇FN₄O₂	보관 (수령일로부터)	3년-20°C분말
CAS 번호	557795-19-4	SDF 다운로드		원액 보관	1년-80°C용매에 보관 1개월-20°C용매에 보관
동의어	SU11248			Smiles	CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C

용해도

In vitro
배치:

DMSO : 25 mg/mL (62.73 mM)
(수분으로 오염된 DMSO는 용해도를 감소시킬 수 있습니다. 신선하고 무수 DMSO를 사용하십시오.)

Ethanol : 8 mg/mL

Water : Insoluble

DMSO : 19 mg/mL (47.68 mM)
(수분으로 오염된 DMSO는 용해도를 감소시킬 수 있습니다. 신선하고 무수 DMSO를 사용하십시오.)

Ethanol : 2 mg/mL

Water : Insoluble

DMSO : 35 mg/mL (87.83 mM)
(수분으로 오염된 DMSO는 용해도를 감소시킬 수 있습니다. 신선하고 무수 DMSO를 사용하십시오.)

Ethanol : 5 mg/mL

Water : Insoluble

DMSO : 25 mg/mL (62.73 mM)
(수분으로 오염된 DMSO는 용해도를 감소시킬 수 있습니다. 신선하고 무수 DMSO를 사용하십시오.)

Water : Insoluble

Ethanol : Insoluble

DMSO : 80 mg/mL (200.76 mM)
(수분으로 오염된 DMSO는 용해도를 감소시킬 수 있습니다. 신선하고 무수 DMSO를 사용하십시오.)

Ethanol : 26 mg/mL

Water : Insoluble

몰농도 계산기

질량	농도	부피	분자량
=	×	×

희석 계산기 분자량 계산기

In vivo 배치:
Homogeneous suspension	CMC-NA	≥5mg/ml	Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Homogeneous suspension	CMC-NA	≥5mg/ml	Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Clear solution	5%DMSO 1 Corn oil Selleck 연구소에서 검증되었습니다. 이 제형에 대한 조정이 필요한 경우 맞춤 테스트를 위해 당사 영업팀에 문의하십시오.	0.880mg/ml (2.21mM)	Taking the 1 mL working solution as an example, add 50 μL of 17.5 mg/ml clear DMSO stock solution to 950 μL of corn oil and mix evenly. The mixed solution should be used immediately for optimal results.
Homogeneous suspension	CMC-NA	≥5mg/ml	Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Homogeneous suspension	CMC-NA	≥5mg/ml	Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Homogeneous suspension	CMC-NA	≥5mg/ml	Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Clear solution	5%DMSO 1 Corn oil Selleck 연구소에서 검증되었습니다. 이 제형에 대한 조정이 필요한 경우 맞춤 테스트를 위해 당사 영업팀에 문의하십시오.	2.000mg/ml (5.02mM)	Taking the 1 mL working solution as an example, add 50 μL of 40 mg/ml clear DMSO stock solution to 950 μL of corn oil and mix evenly. The mixed solution should be used immediately for optimal results.

생체 내 제형 계산기 (투명한 용액)

1단계: 아래 정보 입력 (권장: 실험 중 손실을 고려하여 추가 동물 포함)

투여량: mg/kg 동물 평균 체중: g 동물당 투여량:μL 동물 수:

2단계: 생체 내 제형 입력 (이것은 계산기일 뿐 제형이 아닙니다. 용해도 섹션에 생체 내 제형이 없는 경우 먼저 당사에 문의하십시오.)

% DMSO + % + % Tween 80 + % ddH₂O

%DMSO+ %

계산 결과:

작업 농도: mg/ml;

DMSO 원액 준비 방법: mg 약물 사전 용해 μL DMSO ( 원액 농도 mg/mL, 농도가 해당 약물 배치의 DMSO 용해도를 초과하는 경우 먼저 당사에 문의하십시오. )

생체 내 제형 준비 방법: 취하다 μL DMSO 원액, 다음 추가μL PEG300, 혼합하고 투명하게 한 다음 추가μL Tween 80, 혼합하고 투명하게 한 다음 추가 μL ddH₂O, 혼합하고 투명하게 합니다.

생체 내 제형 준비 방법: 취하다 μL DMSO 원액, 다음 추가 μL 옥수수 기름, 혼합하고 투명하게 합니다.

참고: 1. 다음 용매를 추가하기 전에 액체가 투명한지 확인하십시오.
2. 용매를 순서대로 추가해야 합니다. 다음 용매를 추가하기 전에 이전 추가에서 얻은 용액이 투명한 용액인지 확인해야 합니다. 와동, 초음파 또는 뜨거운 물 중탕과 같은 물리적 방법을 사용하여 용해를 도울 수 있습니다.

작용 메커니즘

Targets/IC₅₀/Ki	FLT3 (Cell-free assay) c-Kit (Cell-free assay) PDGFRβ (Cell-free assay) 2 nM VEGFR2 (Cell-free assay) 80 nM
시험관 내(In vitro)	Sunitinib은 또한 Kit 및 FLT-3를 강력하게 억제합니다. 이 화합물은 VEGFR2 (Flk1) 및 PDGFRβ의 강력한 ATP 경쟁적 억제제로, K_i는 각각 9 nM 및 8 nM이며, FGFR-1, EGFR, Cdk2, Met, IGFR-1, Abl 및 src보다 VEGFR2 및 PDGFR에 대해 10배 이상 높은 선택성을 나타냅니다. VEGFR2 또는 PDGFRβ를 발현하는 혈청 결핍 NIH-3T3 세포에서, 이 화합물은 VEGF 의존적 VEGFR2 인산화 및 PDGF 의존적 PDGFRβ 인산화를 IC50 각각 10 nM 및 10 nM로 억제합니다. 이 화학물질은 VEGF 유도 혈청 결핍 HUVEC 증식을 IC50 40 nM로 억제하고, PDGFRβ 또는 PDGFRα를 과발현하는 NIH-3T3 세포의 PDGF 유도 증식을 IC50 각각 39 nM 및 69 nM로 억제합니다. 이 화합물은 야생형 FLT3, FLT3-ITD 및 FLT3-Asp835의 인산화를 IC50 각각 250 nM, 50 nM 및 30 nM로 억제합니다. 이 억제제는 MV4;11 및 OC1-AML5 세포의 증식을 IC50 각각 8 nM 및 14 nM로 억제하고, 용량 의존적으로 apoptosis를 유도합니다.
키나아제 분석	생화학적 티로신 키나아제 분석
키나아제 분석	Sunitinib의 VEGFR2 (Flk-1) 및 PDGFRβ에 대한 IC50 값은 RTK의 완전한 세포질 도메인을 포함하는 글루타치온 S-전이효소 융합 단백질을 사용하여 결정됩니다. VEGFR2 (Flk-1) 및 PDGFRβ의 트랜스인산화 활성을 정량하기 위한 생화학적 티로신 키나아제 분석은 펩타이드 기질인 폴리-글루,티르 (4:1)로 사전 코팅된 (PBS에 20 μg/웰; 4 °C에서 밤새 인큐베이션) 96웰 마이크로타이터 플레이트에서 수행됩니다. 과도한 단백질 결합 부위는 PBS에 1-5% (w/v) BSA를 첨가하여 차단됩니다. 정제된 GST-융합 단백질은 바큘로바이러스 감염 곤충 세포에서 생산됩니다. 그런 다음 GST-VEGFR2 및 GST-PDGFRβ를 100 mM HEPES, 50 mM NaCl, 40 μM NaVO₄ 및 0.02% (w/v) BSA로 구성된 2배 농도 키나아제 희석 완충액에 마이크로타이터 웰에 첨가합니다. GST-VEGFR2 또는 GST-PDGFRβ의 최종 효소 농도는 50 ng/mL입니다. 그 후 희석된 이 화합물 25 μL를 각 반응 웰에 첨가하여 각 효소에 적합한 억제제 농도 범위를 생성합니다. 키나아제 반응은 MnCl₂ 용액에 다양한 농도의 ATP를 첨가하여 시작되며, 최종 ATP 농도가 효소의 Km을 포함하도록 하고 최종 MnCl₂ 농도는 10 mM입니다. 플레이트는 EDTA를 첨가하여 반응을 중단하기 전에 실온에서 5-15분 동안 인큐베이션됩니다. 그런 다음 플레이트는 TBST로 세 번 세척됩니다. 토끼 폴리클로널 항인산화 티로신 항혈청을 0.5% (w/v) BSA, 0.025% (w/v) 무지방 건조 우유 및 100 μM NaVO₄를 포함하는 TBST에 1:10,000 희석으로 웰에 첨가하고 37 °C에서 1시간 동안 인큐베이션합니다. 그런 다음 플레이트는 TBST로 세 번 세척하고, 이어서 서양 고추냉이 과산화효소에 접합된 염소 항토끼 항혈청 (TBST에 1:10,000 희석)을 첨가합니다. 플레이트는 37 °C에서 1시간 동안 인큐베이션한 다음 TBST로 세 번 세척됩니다. 각 웰의 인산화 티로신 양은 기질로 2,2′-아지노-디-[3-에틸벤조티아졸린 설포네이트]를 첨가한 후 정량됩니다.
생체 내(In vivo)	생체 내에서 VEGFR2 또는 PDGFR 인산화 및 신호 전달의 실질적이고 선택적인 억제와 일치하게, Sunitinib (20-80 mg/kg/일)은 HT-29, A431, Colo205, H-460, SF763T, C6, A375 또는 MDA-MB-435를 포함한 다양한 종양 이종이식 모델에 대해 광범위하고 강력한 용량 의존적 항종양 활성을 나타냅니다. 이 화합물을 80 mg/kg/일로 21일 동안 투여하면 8마리 중 6마리에서 완전한 종양 퇴행을 유도하며, 치료 종료 후 110일 관찰 기간 동안 종양이 다시 성장하지 않았습니다. 이 화합물의 2차 치료는 1차 치료 동안 완전히 퇴행하지 않은 종양에 대해서도 효과적이었습니다. 이 화합물 치료는 종양 MVD의 유의미한 감소를 가져왔으며, SF763T 신경교종 종양에서 ~40% 감소했습니다. SU11248 치료는 종양 크기 감소가 없었음에도 불구하고 루시페라제 발현 PC-3M 이종이식편의 추가 종양 성장을 완전히 억제했습니다. 이 화합물 치료 (20 mg/kg/일)는 피하 MV4;11 (FLT3-ITD) 이종이식편의 성장을 극적으로 억제하고 FLT3-ITD 골수 이식 모델에서 생존을 연장시킵니다.
참조	[1] https://pubmed.ncbi.nlm.nih.gov/12646019/ [2] https://pubmed.ncbi.nlm.nih.gov/12538485/ [3] https://pubmed.ncbi.nlm.nih.gov/12531805/ [4] https://pubmed.ncbi.nlm.nih.gov/14578466/ [5] https://pubmed.ncbi.nlm.nih.gov/15304385/ [6] https://pubmed.ncbi.nlm.nih.gov/17041096/

적용 분야

방법	바이오마커	이미지	PMID
Western blot	p-AKT / AKT / p-ERK / ERK p-GSK3β / GSK3β / MYCN p-STAT3 / STAT3 / p-Src / Src / p-AKT / AKT / p-ERK / ERK		24759734
Growth inhibition assay	Cell viability		24369536

임상시험 정보

(데이터 출처 https://clinicaltrials.gov, 업데이트 날짜 2024-05-22)

NCT 번호	모집	조건	스폰서/협력자	시작일	단계
NCT06222593	Not yet recruiting	Carcinoma Renal Cell	State University of New York at Buffalo	June 1 2024	Phase 1\|Phase 2
NCT06208748	Not yet recruiting	Gastrointestinal Stromal Tumors\|GIST	Sarcoma Alliance for Research through Collaboration\|Cogent Biosciences Inc.\|Dana-Farber Cancer Institute\|The Life Raft Group	March 2024	Phase 2
NCT05745142	Completed	Carcinoma Renal Cell\|Clear-cell Metastatic Renal Cell Carcinoma	Pfizer	February 23 2023	--
NCT05043090	Recruiting	Papillary Renal Cell Carcinoma	AstraZeneca	October 28 2021	Phase 3
NCT04669366	Completed	Kidney Neoplasms	Pfizer	January 20 2021	--

기술 지원

취급 설명서

Tel: +1-832-582-8158 Ext:3

다른 문의사항이 있으시면 메시지를 남겨주세요.

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):